Predictive capabilities of in vitro colon bioaccessibility for estimating in vivo relative bioavailability of arsenic from contaminated soils: Arsenic speciation and gut microbiota considerations
Predictive capabilities of in vitro colon bioaccessibility for estimating in vivo relative bioavailability of arsenic from contaminated soils: Arsenic speciation and gut microbiota considerations
复制标题
体外结肠生物可及性的预测能力,用于估计受污染土壤中砷的体内相对生物利用度:砷形态和肠道微生物群考虑因素
DOI:
10.1016/j.scitotenv.2021.151804
复制
发表时间:
2022
影响因子:
9.8
通讯作者:
Yanshan Cui
中科院分区:
文献类型:
--
作者:
Naiyi Yin;Xiaolin Cai;Pengfei Wang;Run Feng;Huili Du;Yaqi Fu;Guoxin Sun;Yanshan Cui
Arsenic (As) transformation by human gut microbiota has been evidenced to impact As toxicity and human health. However, little is known about the influence of gut microbiota on As bioavailability from incidental ingestion of soil. In this study, we assessed As relative bioavailability (RBA) using anin vivomouse model and As bioaccessibility in the colon phase ofin vitroassays. Strongin vivo-in vitrocorrelations (R2= 0.70–0.92,P< 0.05) were observed between soil As RBA (10.2%–57.7%) and colon bioaccessibility (4.8%–49.0%) in 13 As-contaminated soils. Uponin vitroincubation of human colon microbiota, we found a high degree of As transformation and 65.9% of generated As(III) was observed in soil residues. Forin vivomouse assay, DMA(V) accounted for 79.0% of cumulative urinary As excretion. Except for As(V), dominant As species including As(III), DMA(V) and As sulfides were also detected in mouse feces. Gut bacteria (familiesRikenellaceaeandMarinifilaceae) could be significantly correlated with As intake and excretion in mice (P< 0.05). Our findings provide evidence that gut microbiota can affect transformation, bioavailability, and fate of the orally ingested soil As in human gastrointestinal tract.